BioCorRx Completes $2.25 Million Private Placement
March 02, 2021 09:24 ET
|
BioCorRx Inc
ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Appoints Finance Veteran Joseph J. Galligan to the Board of Directors
February 24, 2021 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Partners with Truusight Health to Integrate Recovery Program Into Self-Funded Health Plans
October 13, 2020 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Oct. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx®”) (“Company”), a developer and provider of advanced solutions in the treatment of substance...
BioCorRx Provides Business Update for the Second Quarter of 2020
August 14, 2020 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic
May 22, 2020 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, May 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Offers Free Access to the UnCraveRx™ Mobile Platform for Weight Loss Management During COVID-19 Pandemic
April 10, 2020 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, April 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Offers Free Access to the BioCorRx Recovery Program Mobile Platform for Medical Professionals During COVID-19 Pandemic
April 07, 2020 10:24 ET
|
BioCorRx Inc
ANAHEIM, CA, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Announces Senior Management Promotions
March 02, 2020 09:26 ET
|
BioCorRx Inc
Lourdes Felix Promoted to President Tom Welch Promoted to Executive Vice President ANAHEIM, CA, March 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the...
BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder
January 30, 2020 09:31 ET
|
BioCorRx Inc
ANAHEIM, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Provides 2019 Year-End Business Update
December 19, 2019 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...